BRAINSTORM: A multi-institutional phase 1/2 study of RRx-001 in combination with whole brain radiation therapy for patients with brain metastases

Authors

Michelle M Kim, University of Michigan-Ann Arbor
Christina I Tsien, Washington University School of Medicine in St. Louis
et al

Journal

International journal of radiation oncology, biology, physics

Publication Date

7-1-2020

Volume

107

Issue

3

First Page

478

Last Page

486

Document Type

Open Access Publication

DOI

10.1016/j.ijrobp.2020.02.639

Rights and Permissions

Kim MM, Parmar HA, Schipper M, Devasia T, Aryal MP, Kesari S, O'Day S, Morikawa A, Spratt DE, Junck L, Mammoser A, Hayman JA, Lawrence TS, Tsien CI, Aiken R, Goyal S, Abrouk N, Trimble M, Cao Y, Lao CD. BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):478-486. doi: 10.1016/j.ijrobp.2020.02.639. Epub 2020 Mar 10. PMID: 32169409. Ó2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). https://doi.org/10.1016/j.ijrobp.2020.02.639www.redjournal.org

Recommended Citation

Kim, Michelle M; Tsien, Christina I; and et al, "BRAINSTORM: A multi-institutional phase 1/2 study of RRx-001 in combination with whole brain radiation therapy for patients with brain metastases." International journal of radiation oncology, biology, physics. 107, 3. 478 - 486. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9497